Biochemical and Biophysical Research Communications · 1997 · 61 citations · 29 references
Life SciencesNeurobiologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationDementia Risk FactorsNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of DementiaAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid PlaquesAmyloidogenic ProteinsConformational TransitionsLate Onset Alzheimer DiseaseNeuritic Plaques
The inheritance of the apolipoprotein (apo) E4 allele is an important risk factor for late-onset Alzheimer's disease (AD). A major component of the Alzheimer's disease neuritic plaques is amyloid beta (A beta). We previously identified apoE/A beta complexes within neuritic plaques (1). It was not known if this interaction takes place before or after A beta peptides become incorporated into neuritic plaques. To address this question we sought evidence of apoE complexes with brain soluble A beta peptides in AD and control patients. In addition, numerous proteins have been shown to bind A beta peptides in vitro. It is not know if any of these bind brain sA beta in vivo. We found evidence for the presence of apoE/dimeric sA beta complexes in the AD brain and could not detect complexes with other A beta peptide binding proteins. The binding of sA beta to apoE may be one factor influencing its clearance from the brain and/or its conformational state.
29
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text
Life Sciences, Genetics, Neurology +17
D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter et al. · Proceedings of the National Academy of Sciences · 1993 · 1.5K citations · Full text